Skip to main content
. 2020 Apr 14;10:6398. doi: 10.1038/s41598-020-62193-7

Figure 3.

Figure 3

Syncytin-1 expression in preeclampsia patients compared to healthy pregnant controls. (A) EVs from women were analyzed for PLAP expression by Western Blot. Similar levels of PLAP were seen in non-pregnant female controls compared to pregnant women. Presence of flotillin-1 suggested that EVs isolated utilizing methodology detailed yielded nanoparticles enriched in exosomes. The blots were cropped from different gels. (B) Maternal plasma EV samples were analyzed for syncytiotrophoblast protein marker expression by Western blot. Similar levels of PLAP were seen in preeclampsia versus control samples. Lower levels of syncytin-1 were seen in preeclampsia subjects compared to healthy pregnant controls. Canonical exosome marker, flotillin-1, is shown as positive control. The blots were cropped from different parts of the same gel. Normalized values to flotillin-1 are represented for Syncytin-1 and PLAP for pregnant control (red) and preeclampsia subject (blue). (C) RT-PCR analysis of plasma EV mRNA showed similar levels of syncytin-1 in both preeclampsia and control subjects. The blots were cropped from different parts of the same gel.